BIO-TECHNE

Live / Allowed — Notice of allowance issued (as of 10 Mar 2026)

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Jun 2025 filing date already counts against anyone who files later.

Record

Serial number
99254492
Mark type
Stylized text
Filed
26 Jun 2025
Published for opposition
13 Jan 2026
Attorney of record
Courtney Thompson

Goods and services

  • Class 001 — Chemicals: Reagents and chemicals for scientific research, medical research, clinical research, life science research, laboratory research, pharmaceutical research, and diagnostic reagents for scientific use; reagents, namely recombinant proteins and antibodies, for scientific research, medical research, clinical research, life science research, laboratory research, pharmaceutical research, and diagnostic reagents for scientific use; biological cell culture media for scientific purposes and for research in the fields of medical, clinical, life science, laboratory and pharmaceutical research, biological cell culture media for diagnostic use for scientific purposes; assays for research purposes; fluorescent dyes for scientific purposes and for research in the fields of medical, clinical, life science, laboratory and pharmaceutical research, and for diagnostic use for scientific purposes; oligonucleotides for scientific purposes and for research in the fields of medical, clinical, life science, laboratory and pharmaceutical research, and for diagnostic use for scientific purposes; enzymes for scientific and research purposes.
  • Class 005 — Pharmaceuticals: Reagents and diagnostic reagents for clinical medical use; chemicals for clinical medical use, namely, for diagnosing, detecting, prognosing, stratifying or selecting therapy for a disease condition, including cancer and inherited genetic disorders; antibodies for medical purposes; proteins for medical diagnosis purposes; oligonucleotides for medical diagnostic purposes; culture media for cultivating human and animal cells for medical or clinical use; reagents and media for medical and veterinary diagnostic purposes; biological reagents, namely, clinical medical reagents; diagnostic preparations for medical use, namely, western blot.
  • Class 009 — Scientific and electric apparatus: Instrumentation for life science research, namely, instruments to identify, quantify, and characterize proteins, analyze particles in biological samples, perform immunoassays, and to dispense and characterize cells, namely, protein detection and analysis instruments being automated western blot and imaged capillary electrophoresis instruments, immunoassay instruments, cell sorter and single cell dispenser instruments, and cell and tissue imaging analysis systems; instrumentation for life science research, namely, instruments for quality control and analysis in the manufacture of therapeutic products in the nature of micro-flow imaging systems; multiplexers; microplate readers in the nature of apparatuses and instruments used to detect and measure assays in microtiter plates; microplate readers in the nature of apparatuses and instruments used to detect and measure absorbance at different light wavelengths for immunoassays; microplate readers in the nature of apparatuses and instruments used to detect and measure assays in plates for research, bioassays, drug discovery, and manufacturing; protein analysis equipment comprised of computer hardware, recorded software, and display screens for protein detection, imaging, and quantitative analysis for use in genetic research, antibody research, biomarker discovery, and biotherapeutics production; laboratory apparatus, namely, protein sample fractionators; computer hardware and peripherals; downloadable software for multiplexing; laboratory apparatus, namely, electrophoresis apparatus not for medical purposes, in particular for western blot processing.
  • Class 010 — Medical apparatus: Diagnostic apparatus for medical purposes used in medical laboratories, namely, electophoresis apparatus for western blot processing or automated Enzyme-linked Immunosorbent Assays (ELISAs) platforms for immunoassays.

Owner

Prosecution history

  • 10 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 13 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 13 Jan 2026 — PUBLISHED FOR OPPOSITION
  • 07 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 16 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 15 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 15 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 15 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 16 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 16 Sept 2025 — NON-FINAL ACTION E-MAILED
  • 16 Sept 2025 — NON-FINAL ACTION WRITTEN
  • 08 Sept 2025 — ASSIGNED TO EXAMINER
  • 08 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 26 Jun 2025 — APPLICATION FILING RECEIPT MAILED
  • 26 Jun 2025 — NEW APPLICATION ENTERED

View this trademark record on Marksy